Press release
Online Case Evaluations Available for Women Injured by Vaginal Mesh
Women who have suffered serious complications after receiving a transvaginal mesh implant may now find free legal help online.Los Angeles, CA, December 23, 2011 – In response to the growing number of lawsuits being filed against manufacturers of vaginal mesh devices, a prominent national law firm is now offering free online help to women who are concerned about potential side effects.
Vaginal mesh was first approved the U.S. Food and Drug Administration to treat a condition known as pelvic organ prolapse or POP. The condition is a weakening of the pelvic floor muscles typically caused by childbirth, hysterectomy or weight gain. Women who develop POP may experience incontinence or other adverse side effects.
Since 2008, the FDA has received several thousand complaints from women across the country who claim they were seriously injured by a transvaginal mesh implant. Complications allegedly caused by these devices including severe abdominal pain, internal scarring, blood vessel and tissue damage, infection and pain during intercourse.
In July 2011, the FDA issued an updated safety communication advising women of the potential risks associated with vaginal mesh devices. Since the warning was issued a flood of lawsuits have been filed Johnson & Johnson, C.R. Bard, American Medical Systems and Boston Scientific by women who claim they the devices manufactured by these companies were defective.
A number of these cases have been consolidated in to multidistrict litigations in federal courts across the country. The first bellweather trials in the vaginal mesh litigation are scheduled to begin in November 2012 in a New Jersey Superior Court. These cases involved approximately 600 claims filed against Johnson & Johnson which allege injuries caused by the company’s Ethicon Gynecare mesh system.
While the FDA currently has no plans to issue a recall of any vaginal mesh devices, concerns over the safety of these products prompted the American College of Obstetricians and Gynecologists and the American Urogynecologic Society (AUGS) to issue a joint opinion in November 2011 recommending limiting the use of the implants only to those high-risk women for whom the benefits would outweigh the risks. In addition to these recommendations, members of the U.S. Senate are seeking to require vaginal mesh manufacturers to implement enhanced safety tracking techniques for these devices once they become available to the public.
Prominent national law firm Nadrich & Cohen LLP has created a new online resource center for women in all 50 states who are seeking information about the vaginal mesh litigation. In addition, visitors to www.VaginalMeshLegalClaims.com may also complete a confidential online contact form to schedule a free initial case evaluation. Help is also available by calling the firm’s injury hotline at 1-800-722-0765.
Nadrich & Cohen LLP is a national law firm specializing in representing clients nationwide who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, traffic accidents, workplace accidents and dog bites. To learn more about our firm, visit www.PersonalInjuryLawCal.com.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Online Case Evaluations Available for Women Injured by Vaginal Mesh here
News-ID: 205334 • Views: …
More Releases from Nadrich & Cohen LLP
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.
Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed…
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.
Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.…
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.
Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.
The two-day panel, which is expected…
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.
Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the…
More Releases for Johnson
Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the…
Siltuximab Market Analysis By Top Keyplayers - Johnson & Johnson
The "Siltuximab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Siltuximab Market, 2024-2031
Verified Market Research's most recent report, "Siltuximab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report…
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and…
Ebola Vaccine Market | CanSino Biologics Inc, Johnson & Johnson, Merck,
The global ebola vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ebola vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Medical Devices for Diagnostics in Vitro Market is Thriving Worldwide with Top K …
Market Overview -
According To A Recent Report Published By QYResearch, The Global Medical Devices for Diagnostics in Vitro Market Is Heading Towards The Inclined Path Of Growth With An Exceptional Growth Rate Over The Forecast Period Of 2023-2029. The Report Published Covers All The Aspects Of The Medical Devices for Diagnostics in Vitro Industry, Starting From The Industry Standard, Segments In Which The Industry Operates, Regional…